Tech & Science
For years, B.C.’s biotech sector has rested on the claim that it has spawned two local giants. But the boast is wearing thin. Does B.C. have what it takes to become the next Bay Area, or will we forever be the farm team for big pharmaceuticals eager to pluck the next great drug discovery and stay stuck in an incubation period? BCBusiness sat down with a round table to discuss.
The Dark Horse of the Year award goes to Aspreva Pharmaceuticals. This young biotech broke through the gate to not only crack the Top 100 public companies list just four years after its inception, but also claim bragging rights as the only biotech in B.C. to record a profit in 2005.
Sinking cash into biotech darlings such as QLT is not for the squeamish, but the payoff could be sweet. Paul Hastings lives in the tortured aftermath of great expectations. Two years before he left northern California to take the helm...